About Wallace Medipharma Private Limited
Data last updated:
Wallace Medipharma Private Limited was a private limited company based in Panaji, Goa, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the real estate financing segment of the financial services sector. It was incorporated on 19 February 1998.
The company was registered with the Registrar of Companies (ROC), Goa, under CIN U24232GA1998PTC002526.
The company had an authorised share capital of ₹50 Lakh and a paid-up capital of ₹9.2 Lakh.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at House No. 302 Edc Complex Patto, Panaji, Goa, India – 403001.
As per the financials filed for FY 2019, the company reported a revenue of ₹1.54 Lakh, a decline of 64% compared to the previous year. For the same year it recorded a net profit of ₹1.03 Lakh (net margin 66.9%) and EBITDA of ₹85,813 (EBITDA margin 55.7%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years.
The last known website on record is wallacepharma.net.
Company details
Contact details
Wallace Medipharma Private Limited's registered office is in Panaji, Goa. Its website is wallacepharma.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressHouse No. 302 Edc Complex Patto, Panaji, Goa, India – 403001
- IndustryFinancial Services, Real Estate Financing
To see the full contact details of Wallace Medipharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Wallace Medipharma is real estate. In detail, this covers real estate activities on fee or contract basis.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| L | Real Estate | L2 | Real estate activities on fee or contract basis |
To see the full business activity and turnover split of Wallace Medipharma Private Limited, buy the company report.
Financials of Wallace Medipharma Private Limited
FY 2019 filings availableWallace Medipharma Private Limited reported revenue of ₹1.54 Lakh (down 64% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 25% over three years, including a 64% fall in the latest year. EBITDA fell 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹85,813 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 55.7% | ||||
| Net Profit Margin | 66.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wallace Medipharma Private Limited, buy the company report.
Board of directors of Wallace Medipharma Private Limited
Wallace Medipharma has 3 former directors on record and no current directors listed.
Shareholding
The shareholding of Wallace Medipharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Wallace Medipharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wallace Medipharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wallace Medipharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Wallace Medipharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Wallace Medipharma Private Limited has 3 board changes on record since 2016: 0 appointments and 3 cessations. The latest: Cesar Mauricio Jose De Menezes ceased to be Director on 25 Feb 2020.
Frequently asked questions
Wallace Medipharma has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Wallace Medipharma was a private limited company based in Panaji, Goa, India. The company worked in real estate financing, within the financial services industry. It was incorporated on 19 February 1998 and is registered under CIN U24232GA1998PTC002526. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Wallace Medipharma is U24232GA1998PTC002526. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wallace Medipharma was incorporated on 19 February 1998. It is registered with the Registrar of Companies, Goa.
Wallace Medipharma can be reached through the website wallacepharma.net. Its registered office is in Panaji, Goa, India.
The registered office of Wallace Medipharma is at House No. 302 Edc Complex Patto, Panaji, Goa, India – 403001.
The latest financial statements of Wallace Medipharma on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
Wallace Medipharma operated in the financial services industry, in the real estate financing segment.
Cesar Mauricio Jose De Menezes ceased to be Director on 25 Feb 2020. Maria Emilia Dias Menezes ceased to be Director on 25 Feb 2020. Rashmi Menezes ceased to be Director on 23 Dec 2016.
The compliance status of Wallace Medipharma is compliant as of 23 August 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
